EGFR and non-small cell lung carcinoma: Because HER3 couples EGFR to the PI3K-Akt pathway in gefitinib-sensitive NSCLC cell lines harboring both wild-type and mutant EGFR (Engelman et al, 2005), we also investigated the correlation of HER3 with P-Akt.